Competitive Interaction Between Fibroblast Growth Factor 23 And Asymmetric Dimethylarginine in Patients With CKD

Both fibroblast growth factor 23 (FGF-23) and asymmetric dimethylarginine (ADMA) are associated with progression of CKD. We tested the hypothesis that ADMA and FGF23 are interactive factors for CKD progression in a cohort of 758 patients with CKD in Southern Europe (mean eGFR±SD, 36±13 ml/min per 1....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Tripepi, Giovanni, Kollerits, Barbara, Leonardis, Daniela, Yilmaz, Mahamut Ilker, Postorino, Maurizio, Fliser, Danilo, Mallamaci, Francesca, Kronenberg, Florian, Zoccali, Carmine
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2015
Assuntos:
Clinical Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4378102/
https://ncbi.nlm.nih.gov/pubmed/25150156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013121355
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados